HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive…

今日の抄読会 Early AMPLE試験。なかなかこれの結果を実臨床で実感するのは難しい（ほんまにそうなん？って感じ）ですが、HLAとは？とかshared epitopeって知ってる？的な学びを加味して提示しました。 https://t.co/VHymeCcEUH

HSS professionals investigate the relationship between clinical response to abatacept and to adalimumab and presence of risk alleles encoding human leukocyte antigen (HLA)-DRB1 shared epitope (SE) in RA. #rheumtwitter @HSS_PIC @BykerkVivian Read: https:/